Skip to main content
Top
Published in: Cancer Causes & Control 4/2013

01-04-2013 | Brief report

Consumption of flaxseed, a rich source of lignans, is associated with reduced breast cancer risk

Authors: Elizabeth C. Lowcock, Michelle Cotterchio, Beatrice A. Boucher

Published in: Cancer Causes & Control | Issue 4/2013

Login to get access

Abstract

Purpose

To investigate the association between intake of flaxseed—the richest source of dietary lignans (a class of phytoestrogens)—and breast cancer risk.

Methods

A food frequency questionnaire was used to measure the consumption of flaxseed and flax bread by 2,999 women with breast cancer and 3,370 healthy control women who participated in the Ontario Women’s Diet and Health Study (2002–2003). Logistic regression was used to investigate associations between consumption of flaxseed and flax bread and breast cancer risk. Confounding by established and suspected breast cancer risk factors, as well as dietary factors, was assessed.

Results

Flaxseed or flax bread was consumed at least weekly by 21 % of control women. None of the 19 variables assessed were identified as confounders of the associations between flaxseed or flax bread and breast cancer risk. Consumption of flaxseed was associated with a significant reduction in breast cancer risk (odds ratio (OR) = 0.82, 95 % confidence interval (CI) 0.69–0.97), as was consumption of flax bread (OR = 0.77, 95 % CI 0.67–0.89).

Conclusions

This Canadian study is, to our knowledge, the first to report on the association between flaxseed alone and breast cancer risk and has found that flaxseed intake is associated with a reduction in breast cancer risk. As dietary intake of flaxseed is modifiable, this finding may be of public health importance with respect to breast cancer prevention.
Literature
1.
go back to reference Buck K, Zaineddin AK, Vrieling A, Linseisen J, Chang-Claude J (2010) Meta-analyses of lignans and enterolignans in relation to breast cancer risk. Am J Clin Nutr 92:141–153PubMedCrossRef Buck K, Zaineddin AK, Vrieling A, Linseisen J, Chang-Claude J (2010) Meta-analyses of lignans and enterolignans in relation to breast cancer risk. Am J Clin Nutr 92:141–153PubMedCrossRef
2.
go back to reference Velentzis LS, Cantwell MM, Cardwell C, Keshtgar MR, Leathem AJ, Woodside JV (2009) Lignans and breast cancer risk in pre- and post-menopausal women: meta-analyses of observational studies. Br J Cancer 100:1492–1498PubMedCrossRef Velentzis LS, Cantwell MM, Cardwell C, Keshtgar MR, Leathem AJ, Woodside JV (2009) Lignans and breast cancer risk in pre- and post-menopausal women: meta-analyses of observational studies. Br J Cancer 100:1492–1498PubMedCrossRef
3.
go back to reference Thompson LU, Boucher BA, Liu Z, Cotterchio M, Kreiger N (2006) Phytoestrogen content of foods consumed in Canada, including isoflavones, lignans, and coumestan. Nutr Cancer 54:184–201PubMedCrossRef Thompson LU, Boucher BA, Liu Z, Cotterchio M, Kreiger N (2006) Phytoestrogen content of foods consumed in Canada, including isoflavones, lignans, and coumestan. Nutr Cancer 54:184–201PubMedCrossRef
4.
go back to reference Milder IE, Arts IC, van de Putte B, Venema DP, Hollman PC (2005) Lignan contents of Dutch plant foods: a database including lariciresinol, pinoresinol, secoisolariciresinol and matairesinol. Br J Nutr 93:393–402PubMedCrossRef Milder IE, Arts IC, van de Putte B, Venema DP, Hollman PC (2005) Lignan contents of Dutch plant foods: a database including lariciresinol, pinoresinol, secoisolariciresinol and matairesinol. Br J Nutr 93:393–402PubMedCrossRef
5.
go back to reference Keinan-Boker L, van Der Schouw YT, Grobbee DE, Peeters PH (2004) Dietary phytoestrogens and breast cancer risk. Am J Clin Nutr 79:282–288PubMed Keinan-Boker L, van Der Schouw YT, Grobbee DE, Peeters PH (2004) Dietary phytoestrogens and breast cancer risk. Am J Clin Nutr 79:282–288PubMed
6.
go back to reference Fink BN, Steck SE, Wolff MS et al (2007) Dietary flavonoid intake and breast cancer risk among women on Long Island. Am J Epidemiol 165:514–523PubMedCrossRef Fink BN, Steck SE, Wolff MS et al (2007) Dietary flavonoid intake and breast cancer risk among women on Long Island. Am J Epidemiol 165:514–523PubMedCrossRef
7.
go back to reference Touillaud MS, Thiébaut AC, Fournier A, Niravong M, Boutron-Ruault MC, Clavel-Chapelon F (2007) Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status. J Natl Cancer Inst 99:475–486PubMedCrossRef Touillaud MS, Thiébaut AC, Fournier A, Niravong M, Boutron-Ruault MC, Clavel-Chapelon F (2007) Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status. J Natl Cancer Inst 99:475–486PubMedCrossRef
8.
go back to reference Hedelin M, Löf M, Olsson M, Adlercreutz H, Sandin S, Weiderpass E (2008) Dietary phytoestrogens are not associated with risk of overall breast cancer but diets rich in coumestrol are inversely associated with risk of estrogen receptor and progesterone receptor negative breast tumors in Swedish women. J Nutr 138:938–945PubMed Hedelin M, Löf M, Olsson M, Adlercreutz H, Sandin S, Weiderpass E (2008) Dietary phytoestrogens are not associated with risk of overall breast cancer but diets rich in coumestrol are inversely associated with risk of estrogen receptor and progesterone receptor negative breast tumors in Swedish women. J Nutr 138:938–945PubMed
9.
go back to reference Suzuki R, Rylander-Rudqvist T, Saji S, Bergkvist L, Adlercreutz H, Wolk A (2008) Dietary lignans and postmenopausal breast cancer risk by oestrogen receptor status: a prospective cohort study of Swedish women. Br J Cancer 98:636–640PubMedCrossRef Suzuki R, Rylander-Rudqvist T, Saji S, Bergkvist L, Adlercreutz H, Wolk A (2008) Dietary lignans and postmenopausal breast cancer risk by oestrogen receptor status: a prospective cohort study of Swedish women. Br J Cancer 98:636–640PubMedCrossRef
10.
go back to reference McCann SE, Hootman KC, Weaver AM et al (2010) Dietary intakes of total and specific lignans are associated with clinical breast tumor characteristics. J Nutr 142:91–98 McCann SE, Hootman KC, Weaver AM et al (2010) Dietary intakes of total and specific lignans are associated with clinical breast tumor characteristics. J Nutr 142:91–98
11.
go back to reference Cotterchio M, Boucher BA, Kreiger N, Mills CA, Thompson LU (2008) Dietary phytoestrogen intake–lignans and isoflavones–and breast cancer risk (Canada). Cancer Causes Control 19:259–272PubMedCrossRef Cotterchio M, Boucher BA, Kreiger N, Mills CA, Thompson LU (2008) Dietary phytoestrogen intake–lignans and isoflavones–and breast cancer risk (Canada). Cancer Causes Control 19:259–272PubMedCrossRef
12.
go back to reference Hedelin M, Klint A, Chang ET et al (2006) Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the cancer prostate Sweden study (Sweden). Cancer Causes Control 17:169–180PubMedCrossRef Hedelin M, Klint A, Chang ET et al (2006) Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the cancer prostate Sweden study (Sweden). Cancer Causes Control 17:169–180PubMedCrossRef
13.
go back to reference Thanos J, Cotterchio M, Boucher BA, Kreiger N, Thompson LU (2006) Adolescent dietary phytoestrogen intake and breast cancer risk (Canada). Cancer Causes Control 17:1253–1261PubMedCrossRef Thanos J, Cotterchio M, Boucher BA, Kreiger N, Thompson LU (2006) Adolescent dietary phytoestrogen intake and breast cancer risk (Canada). Cancer Causes Control 17:1253–1261PubMedCrossRef
14.
go back to reference Anderson LN, Cotterchio M, Vieth R, Knight JA (2010) Vitamin D and calcium intakes and breast cancer risk in pre- and post-menopausal women. Am J Clin Nutr 91:1699–1707PubMedCrossRef Anderson LN, Cotterchio M, Vieth R, Knight JA (2010) Vitamin D and calcium intakes and breast cancer risk in pre- and post-menopausal women. Am J Clin Nutr 91:1699–1707PubMedCrossRef
15.
go back to reference Boucher B, Cotterchio M, Kreiger N, Nadalin V, Block T, Block G (2006) Validity and reliability of the Block98 food-frequency questionnaire in a sample of Canadian women. Public Health Nutr 9:84–93PubMedCrossRef Boucher B, Cotterchio M, Kreiger N, Nadalin V, Block T, Block G (2006) Validity and reliability of the Block98 food-frequency questionnaire in a sample of Canadian women. Public Health Nutr 9:84–93PubMedCrossRef
17.
go back to reference Maldonado G, Greenland S (1993) Simulation study of confounder selection strategies. Am J Epidemiol 138:923–936PubMed Maldonado G, Greenland S (1993) Simulation study of confounder selection strategies. Am J Epidemiol 138:923–936PubMed
18.
go back to reference Zaineddin AK, Buck K, Vrieling A et al (2012) The association between dietary lignans, phytoestrogen-rich foods, and fiber intake and postmenopausal breast cancer risk: a German case–control study. Nutr Cancer 64:652–665PubMedCrossRef Zaineddin AK, Buck K, Vrieling A et al (2012) The association between dietary lignans, phytoestrogen-rich foods, and fiber intake and postmenopausal breast cancer risk: a German case–control study. Nutr Cancer 64:652–665PubMedCrossRef
19.
go back to reference Hanna KL, O’Neill S, Lyons-Wall PM (2010) Intake of isoflavone and lignan phytoestrogens and associated demographic and lifestyle factors in older Australian women. Asia Pac J Clin Nutr 19:540–549PubMed Hanna KL, O’Neill S, Lyons-Wall PM (2010) Intake of isoflavone and lignan phytoestrogens and associated demographic and lifestyle factors in older Australian women. Asia Pac J Clin Nutr 19:540–549PubMed
20.
go back to reference Pan A, Yu D, Demark-Wahnefried W, Franco OH, Lin X (2009) Meta-analysis of the effects of flaxseed interventions on blood lipids. Am J Clin Nutr 90:288–297PubMedCrossRef Pan A, Yu D, Demark-Wahnefried W, Franco OH, Lin X (2009) Meta-analysis of the effects of flaxseed interventions on blood lipids. Am J Clin Nutr 90:288–297PubMedCrossRef
21.
go back to reference Pan A, Sun J, Chen Y et al (2007) Effects of a flaxseed-derived lignan supplement in type 2 diabetic patients: a randomized, double-blind, cross-over trial. PLoS ONE 2:e1148PubMedCrossRef Pan A, Sun J, Chen Y et al (2007) Effects of a flaxseed-derived lignan supplement in type 2 diabetic patients: a randomized, double-blind, cross-over trial. PLoS ONE 2:e1148PubMedCrossRef
22.
go back to reference Pan A, Demark-Wahnefried W, Ye X et al (2009) Effects of a flaxseed-derived lignan supplement on C-reactive protein, IL-6 and retinol-binding protein 4 in type 2 diabetic patients. Br J Nutr 101:1145–1149PubMedCrossRef Pan A, Demark-Wahnefried W, Ye X et al (2009) Effects of a flaxseed-derived lignan supplement on C-reactive protein, IL-6 and retinol-binding protein 4 in type 2 diabetic patients. Br J Nutr 101:1145–1149PubMedCrossRef
23.
go back to reference Willett W (1998) Nutritional epidemiology, 2nd edn. Oxford University Press, New YorkCrossRef Willett W (1998) Nutritional epidemiology, 2nd edn. Oxford University Press, New YorkCrossRef
Metadata
Title
Consumption of flaxseed, a rich source of lignans, is associated with reduced breast cancer risk
Authors
Elizabeth C. Lowcock
Michelle Cotterchio
Beatrice A. Boucher
Publication date
01-04-2013
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 4/2013
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-013-0155-7

Other articles of this Issue 4/2013

Cancer Causes & Control 4/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine